This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Hormone Therapy Has Many Favorable Effects In Newly Menopausal Women: Initial Findings Of The Kronos Early Estrogen Prevention Study (KEEPS)

About FundingThe core KEEPS was funded by the Phoenix-based Kronos Longevity Research Institute which is supported by the not-for-profit Aurora Foundation and carried out at nine U.S. academic medical centers (see below). The Cognitive and Affective Study is National Institutes of Health funded ancillary study of KEEPS that was coordinated by investigators based at the University of Wisconsin in Madison, WI.

About KLRIKLRI is a not-for-profit 501(c)(3) organization that conducts state-of-the-art clinical translational research on the prevention of age-related diseases and ways to increase longevity. Translational research is the critical link between findings from the basic research laboratory and corresponding improvements in clinical care. For more information on KEEPS, visit or call 1(866) 878-1221.

The nine KEEPS study centers

  • Kronos Longevity Research Institute (the Sponsor) (Dr. Mitch Harman, PI)
  • Albert Einstein College of Medicine/Montefiore Medical Center ( New York City; Drs. Nanette Santoro and Genevieve Neal-Perry, PIs)
  • Columbia University College of Physicians and Surgeons ( New York City, Dr. Rogerio Lobo, PI)
  • Harvard Medical School/Brigham and Women's Hospital ( Boston, Dr. JoAnn Manson, PI)
  • Mayo Clinic College of Medicine ( Rochester, MN, Dr. Virginia Miller, PI)
  • University of California, San Francisco/Center for Reproductive Health (Dr. Marcelle Cedars, PI)
  • University of Utah School of Medicine ( Salt Lake City, Drs. Eliot Brinton and Paul Hopkins, PIs)
  • University of Washington School of Medicine ( Seattle, Dr. George Merriam, PI)
  • Yale University School of Medicine ( New Haven, CT, Dr. Hugh Taylor, PI)

Evaluation of arterial imaging was coordinated by

  • Atherosclerosis Research Unit, Keck School of Medicine of USC (CIMT, Dr. Howard Hodis)
  • St. Johns Cardiovascular Research Center and the UCLA School of Medicine (CAC, Dr. Matthew Budoff)

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs